Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications
Strontium oxide (SrO) nanoparticle and various concentrations of chitosan (CS)-doped SrO nanocomposite were synthesized via co-precipitation method. A variety of characterization techniques including were done for characterizing and qualifying the nanocomposite. X-ray powder diffraction affirmed cubic and tetragonal structure of SrO nanoparticle and CS-doped SrO nanocomposite with a decrease in crystallinity upon doping. Fourier transform infrared spectrum endorsed existing functional groups on CS/SrO surfaces while d-spacing was estimated using high resolution Transmission electron microscopes images. UV-Visible and Photoluminescence spectroscopy spectra showed an increase in band gap energies with an increase in doping concentration. Elemental composition of CS-doped SrO nanocomposite deposited with different doping concentrations was studied using Energy dispersive Spectroscopy. Addition of chitosan resulted in the formation of nanocomposite and rod-like structures that led to enhanced catalytic activity during methylene blue ciprofloxacin degradation in the presence of reducing agent sodium borohydrate at various pH conditions..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 19. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
GOUMRI-SAID SOURAYA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-19, Last update posted on www.tib.eu: 2024-04-04, Last updated: 2024-04-09 |
|---|
| Patentnummer: |
US11931378 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003071251 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003071251 | ||
| 003 | DE-627 | ||
| 005 | 20240409142955.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240409s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003071251 | ||
| 035 | |a (EPA)US11931378 | ||
| 035 | |a (EPA)86766940 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a GOUMRI-SAID SOURAYA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-19, Last update posted on www.tib.eu: 2024-04-04, Last updated: 2024-04-09 | ||
| 520 | |a Strontium oxide (SrO) nanoparticle and various concentrations of chitosan (CS)-doped SrO nanocomposite were synthesized via co-precipitation method. A variety of characterization techniques including were done for characterizing and qualifying the nanocomposite. X-ray powder diffraction affirmed cubic and tetragonal structure of SrO nanoparticle and CS-doped SrO nanocomposite with a decrease in crystallinity upon doping. Fourier transform infrared spectrum endorsed existing functional groups on CS/SrO surfaces while d-spacing was estimated using high resolution Transmission electron microscopes images. UV-Visible and Photoluminescence spectroscopy spectra showed an increase in band gap energies with an increase in doping concentration. Elemental composition of CS-doped SrO nanocomposite deposited with different doping concentrations was studied using Energy dispersive Spectroscopy. Addition of chitosan resulted in the formation of nanocomposite and rod-like structures that led to enhanced catalytic activity during methylene blue ciprofloxacin degradation in the presence of reducing agent sodium borohydrate at various pH conditions. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C08L: Compositions of macromolecular compounds (compositions based on polymerisable monomers c08f, c08g;artificial filaments or fibres d01f;textile treating compositions d06) | |
| 650 | 4 | |a C01F: Compounds of the metals beryllium, magnesium, aluminium, calcium, strontium, barium, radium, thorium, or of the rare earth metals (metal hydrides c01b0006000000;salts of oxyacids of halogens c01b0011000000;peroxides, salts of peroxyacids c01b0015000000;sulfides or polysulfides of magnesium, calcium, strontium, or barium c01b0017420000;thiosulfates, dithionites, polythionates c01b0017640000;compounds containing selenium or tellurium c01b0019000000;binary compounds of nitrogen with metals c01b0021060000;azides c01b0021080000;metal amides c01b0021092000;nitrites c01b0021500000;phosphides c01b0025080000;salts of oxyacids of phosphorus c01b0025160000;carbides c01b0032900000; compounds containing silicon c01b0033000000;compounds containing boron c01b0035000000;compounds having molecular sieve properties but not having base-exchange properties c01b0037000000;compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites, c01b0039000000;cyanides c01c0003080000;salts of cyanic acid c01c0003140000;salts of cyanamide c01c0003160000;thiocyanates c01c0003200000; fermentation or enzyme-using processes for the preparation of elements or inorganic compounds except carbon dioxide c12p0003000000;obtaining metal compounds from mixtures, e.g. ores, which are intermediate compounds in a metallurgical process for obtaining a free metal c22b;production of non-metallic elements or inorganic compounds by electrolysis or electrophoresis c25b) | |
| 650 | 4 | |a cet | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a KANOUN MOHAMMED BENALI |e verfasserin |4 aut | |
| 700 | 0 | |a ALI SALAMAT |e verfasserin |4 aut | |
| 700 | 0 | |a HAIDER JUNAID |e verfasserin |4 aut | |
| 700 | 0 | |a HAIDER ALI |e verfasserin |4 aut | |
| 700 | 0 | |a IKRAM MUHAMMAD |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 19. März |
| 773 | 1 | 8 | |g year:2024 |g day:19 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/86766940/publication/US11931378A1?q=US11931378 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 19 |c 03 | ||